Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-1 Virologic Response”

26 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 26 results

Early research (Phase 1)Study completedNCT03485963
What this trial is testing

HIV-1 Specific T -Cells (HST-NEETs) for HIV-Infected Individuals

Who this might be right for
HIV Infections
Catherine Bollard 7
Post-approval studies (Phase 4)Study completedNCT00615745
What this trial is testing

ONCE - Only Nocturnal Combination Evaluation of Antiretroviral-Experienced HIV 1 Infected Subjects Switching to Atripla

Who this might be right for
HIV Infections
Gilead Sciences 115
Not applicableStudy completedNCT01346878
What this trial is testing

Antiretroviral Resistance Detection by Ultrasensitive Pyrosequencing of the HIV-1 Genome and Virological Response to Antiretroviral Rescue Treatment

Who this might be right for
HIV
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia 143
Not applicableStudy completedNCT03500172
What this trial is testing

HIV Treatment Retention Interventions for Women Living With HIV (Siyaphambili Study)

Who this might be right for
HIV-1 Virologic Response
Johns Hopkins Bloomberg School of Public Health 1,391
Early research (Phase 1)Study completedNCT00002403
What this trial is testing

Safety and Effectiveness of Zintevir (AR177) Given to HIV-Infected Patients

Who this might be right for
HIV Infections
Aronex Pharmaceuticals 12
Not applicableStudy completedNCT04147325
What this trial is testing

Evaluate Virologic Response in Participants Newly Diagnosed With HIV-1

Who this might be right for
HIV
Janssen-Cilag Farmaceutica Ltda. 105
Early research (Phase 1)Study completedNCT00051818
What this trial is testing

Immune and Viral Outcomes of HIV-1 Therapy Interruption

Who this might be right for
HIV Infections
The Wistar Institute 20
Testing effectiveness (Phase 2)Study completedNCT00085917
What this trial is testing

Peginterferon Alpha-2a and Ribavirin to Treat Hepatitis C in HIV-infected Patients

Who this might be right for
Hepatitis CHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 29
Large-scale testing (Phase 3)Study completedNCT00966160
What this trial is testing

CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infections
University of Cologne 215
Early research (Phase 1)Looking for participantsNCT07698600
What this trial is testing

A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV

Who this might be right for
HIV -1 Infection
BioNTech SE 126
Large-scale testing (Phase 3)Study completedNCT01060618
What this trial is testing

Double-method Comparative Study in Order to Predict the Use of Co-receptors From Type 1 HIV: Phenotypic Study (Trofile ESTA®) and Virologic Response to a CCR5 Antagonist in the Short Term

Who this might be right for
HIV Infections
Asociacion para el Estudio de las Enfermedades Infecciosas 58
Testing effectiveness (Phase 2)Study completedNCT00031343
What this trial is testing

The Impact of HAART on Response to Hepatitis C Treatment in Patients Taking Peginterferon Alpha-2b and Ribavirin

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 128
Early research (Phase 1)Study completedNCT00270465
What this trial is testing

Safety and Immune Response to a Prime-Boost Vaccination Schedule in HIV-infected Patients

Who this might be right for
HIV
National Institute of Allergy and Infectious Diseases (NIAID) 17
Large-scale testing (Phase 3)WithdrawnNCT00686270
What this trial is testing

A Long Term Safety Study of Apricitabine in HIV-infected Patients

Who this might be right for
HIV Infections
Avexa
Not applicableUnknownNCT00069485
What this trial is testing

Resistance to HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 100
Large-scale testing (Phase 3)WithdrawnNCT00011128
What this trial is testing

Salvage Treatment, Resistance Testing, and Withdrawal of Anti-HIV Drugs for HIV Patients Failing Current Anti-HIV Treatment

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Post-approval studies (Phase 4)Study completedNCT00772590
What this trial is testing

Antiretroviral Therapy Intensification With Raltegravir or Addition of Hyper-immune Bovine Colostrum in HIV-1 Infected Patients With Suboptimal CD4+ T Cell Response

Who this might be right for
HIV Infections
Kirby Institute 75
Large-scale testing (Phase 3)Study completedNCT01709084
What this trial is testing

A Clinical Trial Comparing the Efficacy of Tenofovir Disoproxil Fumarate/Emtricitabine/Rilpivirine (TDF/FTC/RPV) Versus TDF/FTC/Efavirenz (TDF/FTC/EFV) in Patients With Undetectable Plasma HIV-1 RNA on Current First-line Treatment

Who this might be right for
Human Immunodeficiency Virus-type 1 Infection
Janssen-Cilag International NV 426
Post-approval studies (Phase 4)Ended earlyNCT01443923
What this trial is testing

Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV

Who this might be right for
HepatitisHIV/AIDS
National Institute of Allergy and Infectious Diseases (NIAID) 4
Not applicableStudy completedNCT03251690
What this trial is testing

Switching TDF/FTC/EFV to TDF/FTC/RPV VS Continuing TDF/FTC/EFV in HIV Patients With Complete Virological Suppression

Who this might be right for
Anti-Retroviral AgentsEfavirenzHIV-1-infection+3 more
Mahidol University 246
Next Page